Serotonin reuptake inhibitors (SRIs) and the risk of fetal congenital heart anomalies (CHA): An exploratory pharmacogenetics study

被引：0
|
作者：
Daud, A. N. A. [1 ,2 ]
Bergman, J. E. H. [3 ]
Kerstjens-Frederikse, W. S. [3 ]
van der Vlies, P. [3 ]
Hak, E. [1 ]
Berger, R. M. F. [4 ]
Groen, H. [5 ]
Wilffert, B. [1 ]
机构：
[1] Univ Groningen, Dept Pharm, Groningen, Netherlands
[2] Univ Sains Malaysia, Sch Pharmaceut Sci, George Town, Malaysia
[3] Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands
[4] Univ Med Ctr Groningen, Dept Pediat Cardiol, Groningen, Netherlands
[5] Univ Groningen, Dept Epidemiol, Groningen, Netherlands
来源：
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY | 2017年 / 390卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
100
引用
收藏
页码：S24 / S24
页数：1
相关论文
共 50 条
  • [1] Prenatal exposure to serotonin reuptake inhibitors and congenital heart anomalies: an exploratory pharmacogenetics study
    Daud, Aizati N. A.
    Bergman, Jorieke E. H.
    Kerstjens-Frederikse, Wilhelmina S.
    van der Vlies, Pieter
    Hak, Eelko
    Berger, Rolf M. F.
    Groen, Henk
    Wilffert, Bob
    PHARMACOGENOMICS, 2017, 18 (10) : 987 - 1001
  • [2] The Risk of Congenital Heart Anomalies Following Prenatal Exposure to Serotonin Reuptake Inhibitors-Is Pharmacogenetics the Key?
    Daud, Aizati N. A.
    Bergman, Jorieke E. H.
    Kerstjens-Frederikse, Wilhelmina S.
    Groen, Henk
    Wilffert, Bob
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (08)
  • [3] Selective Serotonin Reuptake Inhibitors and Risk for Major Congenital Anomalies
    Spinelli, Margaret
    Puryear, Lucy J.
    Einarson, Adrienne
    OBSTETRICS AND GYNECOLOGY, 2011, 118 (06): : 1420 - 1420
  • [4] Selective Serotonin Reuptake Inhibitors and Risk for Major Congenital Anomalies
    Malm, Heli
    Artama, Miia
    Gissler, Mika
    Ritvanen, Annukka
    OBSTETRICS AND GYNECOLOGY, 2011, 118 (01): : 111 - 120
  • [5] Selective Serotonin Reuptake Inhibitors and Risk for Major Congenital Anomalies
    Petersen, Irene
    Gilbert, Ruth
    Evans, Stephen
    Nazareth, Irwin
    OBSTETRICS AND GYNECOLOGY, 2012, 119 (01): : 182 - 183
  • [6] Selective Serotonin Reuptake Inhibitors and Risk for Major Congenital Anomalies
    Pupco, Anna
    Bozzo, Pina
    Koren, Gideon
    OBSTETRICS AND GYNECOLOGY, 2011, 118 (04): : 959 - 960
  • [7] A comparative study of QT prolongation with Serotonin Reuptake Inhibitors (SRIs)
    Senard-Ojedo, A.
    Chebane, L.
    Araujo, M.
    Rousseau, V.
    Montastruc, F.
    Montastruc, J. L.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2017, 31 : 51 - 51
  • [8] Selective Serotonin Reuptake Inhibitors and Risk for Major Congenital Anomalies Reply
    Malm, Heli
    Artama, Miia
    Gissler, Mika
    Ritvanen, Annukka
    OBSTETRICS AND GYNECOLOGY, 2012, 119 (01): : 183 - 183
  • [9] Risk of fetal anomalies with exposure to selective serotonin reuptake inhibitors - Reply
    Koren, G
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (23): : 1873 - 1873
  • [10] Selective Serotonin Reuptake Inhibitors and Risk for Major Congenital Anomalies Reply
    Malm, Heli
    Artama, Miia
    Ritvanen, Annukka
    Gissler, Mika
    OBSTETRICS AND GYNECOLOGY, 2011, 118 (04): : 960 - 960
12345